David P. Hochman - May 8, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Chief Executive Officer and Chairperson, Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
May 8, 2024
Transactions value $
$0
Form type
4
Date filed
5/10/2024, 05:22 PM
Previous filing
Jul 24, 2023
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +100K +21.48% $0.00 565K May 8, 2024 Direct F1
transaction OBIO Common Stock Award $0 +100K +43.96% $0.00 328K May 8, 2024 By the DPH 2008 Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on June 10, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on September 10, 2025, November 10, 2025, December 10, 2025, June 10, 2026, September 10, 2026, December 10, 2026, March 22, 2027, June 10, 2027, September 10, 2027, December 10, 2027, March 22, 2028 and June 10, 2028, subject to the Reporting Person's continuous service through such dates.

Remarks:

Chief Executive Officer and Chairperson